These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Statistical parameters of transmitter release at frog neuromuscular junctions treated with guanidine or tetraethylammonium. Volle RL, Branisteanu DD. J Pharmacol Exp Ther; 1976 Jun; 197(3):653-61. PubMed ID: 6788 [Abstract] [Full Text] [Related]
29. Neurotransmitter release and nerve terminal morphology at the frog neuromuscular junction affected by the dye Erythrosin B. Augustine GJ, Levitan H. J Physiol; 1983 Jan; 334():47-63. PubMed ID: 6134825 [Abstract] [Full Text] [Related]
30. Modification by lithium of transmitter release at the neuromuscular junction of the frog. Branisteanu DD, Volle RL. J Pharmacol Exp Ther; 1975 Aug; 194(2):362-72. PubMed ID: 239225 [Abstract] [Full Text] [Related]
31. Dual action of erbium on transmitter release at the frog neuromuscular synapse. Metral S, Bonneton C, Hort-Legrand C, Reynes J. Nature; 1978 Feb 23; 271(5647):773-5. PubMed ID: 24184 [No Abstract] [Full Text] [Related]
32. [Effect of calcium ions on bimodal parameters of mediator liberation in frog sartorius muscle neuromuscular junctions]. Zefirov AL. Fiziol Zh SSSR Im I M Sechenova; 1980 Apr 23; 66(4):531-6. PubMed ID: 6104608 [Abstract] [Full Text] [Related]
33. The kinetics of quantal releases during end-plate currents at the frog neuromuscular junction. Van der Kloot W. J Physiol; 1988 Aug 23; 402():605-26. PubMed ID: 2853224 [Abstract] [Full Text] [Related]
34. Run-down of neuromuscular transmission during repetitive nerve activity by nicotinic antagonists is not due to desensitization of the postsynaptic receptor. Hong SJ, Chang CC. Br J Pharmacol; 1991 Apr 23; 102(4):817-22. PubMed ID: 1677297 [Abstract] [Full Text] [Related]
35. [Effect of thiamine on neuromuscular transmission in the frog]. Romanenko AV. Neirofiziologiia; 1985 Apr 23; 17(6):794-800. PubMed ID: 3003595 [Abstract] [Full Text] [Related]
36. Observations on the action of type A botulinum toxin on frog neuromuscular junctions. Boroff DA, del Castillo J, Evoy WH, Steinhardt RA. J Physiol; 1974 Jul 23; 240(2):227-53. PubMed ID: 4371582 [Abstract] [Full Text] [Related]
37. The effect of (+)-tubocurarine on neuromuscular transmission during repetitive stimulation in the rat, mouse, and frog. Magleby KL, Pallotta BS, Terrar DA. J Physiol; 1981 Mar 23; 312():97-113. PubMed ID: 6267269 [Abstract] [Full Text] [Related]
38. Temperature-sensitive aspects of evoked and spontaneous transmitter release at the frog neuromuscular junction. Barrett EF, Barrett JN, Botz D, Chang DB, Mahaffey D. J Physiol; 1978 Jun 23; 279():253-73. PubMed ID: 209175 [Abstract] [Full Text] [Related]
39. The action of dantrolene on transmitter mobilization at the rat neuromuscular junction. Durant NN, Lee C, Katz RL. Eur J Pharmacol; 1980 Dec 19; 68(4):403-8. PubMed ID: 6110552 [Abstract] [Full Text] [Related]
40. Effect of diazepam on the frog neuromuscular junction. Vyskocil F. Eur J Pharmacol; 1978 Mar 01; 48(1):117-24. PubMed ID: 25188 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]